Methyldopa

CAS 555-30-6 6 current records 6 historicalSmall Molecule

Who holds supplier records for Methyldopa? 6 organisations hold a current record for Methyldopa: an active US FDA Type II Drug Master File or a CEP. A further 6 organisations have only historical (inactive) DMF filings. 6 of them hold a valid EU Certificate of Suitability. Recorded organisation countries for current records: China (4), Netherlands (1) and Hungary (1).

Sources: FDA Drug Master File list, EDQM certification database, FDA Orange Book. Record updated 16 Nov 2026. How we read these records

Cite as: PharmaTek, “Methyldopa: DMF and CEP holder records”, record as of 16 Nov 2026, pharmatek.co.uk/directory/api/methyldopa

Reading the evidence

  • 6 current records

    Several organisations hold current DMFs or CEPs. Whether any is a usable source for your grade, scale and market still needs qualification.

  • Most recorded organisations are in China

    4 of the 6 current records with a recorded country list China. Organisation country is not necessarily the manufacturing site.

  • 1 with a company-level GMP certificate on record

    These organisations have at least one current EU or UK GMP certificate somewhere. It is not matched to the site that makes this substance; check the certificate's site and scope.

Current records (6)

Organisations holding an active US FDA Type II Drug Master File or a CEP for Methyldopa. Country is the organisation's recorded country, not necessarily the manufacturing site.

Need Methyldopa sourced and checked?

The Sourcing Desk contacts candidates, confirms current supply, grade and site, and screens each against its regulatory record, for a buyer-paid fixed fee and never a supplier commission.

Request sourcing help

Valid CEP holder entries (6)

Certificates of Suitability on the EDQM register for Methyldopa, including the salts, esters and hydrates the register lists separately; each row shows the substance as named on the certificate. A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer. 8 certificates in total, including withdrawn, expired, suspended and repeat certificates.

HolderCountryCertificateIssuedEU GMP at holder's address
ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO., LTD. Chizhou CityCN
CEP 2025-297 - Rev 00
Methyldopa
Sept 2026—
ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. TaizhouCN
CEP 2025-526 - Rev 00
Methyldopa, Site Yongtai Chiral, Process A
Jan 2026—
TAPI NL B.V. AmsterdamNL
CEP 2010-326 - Rev 06
Methyldopa
Mar 2025—
ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. HangzhouCN
R1-CEP 2018-065 - Rev 00
Methyldopa, Process B
Jun 2023—
EGIS Pharmaceuticals PLC BudapestHU
R1-CEP 1996-033 - Rev 07
Methyldopa
Apr 2019—
ZHEJIANG WILD WIND PHARMACEUTICAL CO., LTD. Geshan TownCN
R1-CEP 2009-120 - Rev 01
Methyldopa
Apr 2018—

The GMP column shows the most recent EU GMP certificate issued for the same address as the holder, joined on the EMA location identifier printed on both documents (EudraGMDP, re-read about once a quarter; withdrawn certificates are excluded). A dash means no certificate carries that identifier, not that the site is uninspected. The holder's address is not necessarily where the substance is made.

Certification Online Database. European Directorate for the Quality of Medicines & HealthCare (EDQM), Council of Europe, (2026), URL: https://extranet.edqm.eu/publications/recherches_CEP.shtml. Accessed 16 Nov 2026. Reproduced with permission and unaltered. The EDQM and the Council of Europe accept no liability for any consequence arising from its use.

Historical records (6)

Organisations whose Type II DMFs for Methyldopa are no longer active. These show a past filing, not current supply.

Show all 6 historical records
  • India · Inactive DMF 17699 · filed Sept 2004
  • FARCHEMIA SRL
    Inactive DMF 6140 · filed Dec 1985
  • Italy · Inactive DMF 5725 · filed Dec 1984
  • ACIC LTD
    Inactive DMF 3472 · filed Feb 1979
  • PLANTEX LTD CHEMICAL AND PHARMACEUTICAL WORKS
    Inactive DMF 3243 · filed Jun 1978
  • Brazil · Inactive DMF 2696 · filed Jun 1976

Overview

Methyldopa is an antihypertensive medication primarily used to treat high blood pressure. It works by stimulating alpha-2 adrenergic receptors in the central nervous system, resulting in decreased sympathetic outflow, which leads to a reduction in blood pressure.

Chemical identity

IUPAC name
bis((2S)-2-amino-3-(3,4-dihydroxyphenyl)-2-methylpropanoic acid);trihydrate
Canonical SMILES
C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.C[C@](CC1=CC(=C(C=C1)O)O)(C(=O)O)N.O.O.O
InChIKey
YKFCISHFRZHKHY-NGQGLHOPSA-N
Synonyms
Aldomet API, aldomet, aldoril component methyldopa, alpha-methyldopa, dopamet, dopegyt, medopren, methyldopa hydrate, methyldopa sesquihydrate, methyldopum, mk-351, nsc-760080

Pharmacologic class

As the US FDA states it for this active substance on product listings.

Established pharmacologic class
Central alpha-2 Adrenergic Agonist
Mechanism of action
Adrenergic alpha2-Agonists

Therapeutic areas

CardiovascularHypertension

Record history

No change to the current records between 13 Nov 2026 and 16 Nov 2026.

Get an email when these records change: at most one a week, only when something changed, and only after you confirm your address. All changes this week

What these records establish

  • An active DMF means a confidential file is held by the FDA and can be referenced; the FDA does not approve or disapprove DMFs.
  • A CEP confirms monograph suitability for the EU market; it is not a GMP certificate, and the holder may not be the manufacturer.
  • Historical records show a past filing, not current supply.
  • Company GMP certificates are matched to the organisation, not to the site making this substance.
  • A substance missing from these registers is not evidence that no supplier exists.

Frequently asked questions

Which organisations hold current supplier records for Methyldopa?

6 organisations hold an active US FDA Type II Drug Master File or a CEP for Methyldopa: TAPI NL BV (Netherlands), Zhejiang Chiral Medicine Chemicals Co., Ltd. (China), Zhejiang Wild Wind Pharmaceutical Co.,Ltd. (China), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD (China), ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO LTD (China) and Egis Pharmaceuticals PLC (Hungary). A DMF or CEP shows a regulatory filing, not current commercial availability, and the holder is not necessarily the manufacturing site.

Which Methyldopa Drug Master Files are active?

TAPI NL BV (DMF 26726), Zhejiang Chiral Medicine Chemicals Co., Ltd. (DMF 20565), Zhejiang Wild Wind Pharmaceutical Co.,Ltd. (DMF 22425) and ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO LTD (DMF 42829). The FDA does not approve or disapprove DMFs; an active DMF can be referenced in an application once its holder issues a letter of authorisation.

What do the historical Methyldopa records mean?

6 organisations have only inactive Type II DMFs for Methyldopa. An inactive DMF records that a filing once existed; it does not show that the organisation supplies the substance today.

Does Methyldopa have a European Certificate of Suitability?

Yes. 6 organisations hold a valid CEP for Methyldopa on the EDQM register, including ANHUI BIOCOMPOUNDS PHARMACEUTICAL CO., LTD. Chizhou City (CN), ZHEJIANG YONGTAI CHIRAL MEDICINE TECHNOLOGY CO. LTD. Taizhou (CN), TAPI NL B.V. Amsterdam (NL), ZHEJIANG CHIRAL MEDICINE CHEMICALS CO., LTD. Hangzhou (CN), EGIS Pharmaceuticals PLC Budapest (HU) and ZHEJIANG WILD WIND PHARMACEUTICAL CO., LTD. Geshan Town (CN). A CEP confirms the substance can be controlled by the European Pharmacopoeia monograph; it is not a GMP certificate, and the holder is not necessarily the manufacturer.

How do I qualify a Methyldopa supplier?

Confirm the DMF or CEP is current and covers your grade, obtain the letter of authorisation, identify the actual manufacturing site and check its GMP certificate and FDA inspection history, audit the site or review a recent audit, and run comparable requests for information across more than one candidate.

For suppliers

Do you supply Methyldopa?

Send a link to a certificate, registration or filing we have missed or got wrong. We check it against the issuing register before changing anything; information we cannot check against a register is shown as supplier-reported.

Free. Payment never buys an evidence status.